Table 1 Baseline demographics and patient characteristics
Characteristic | Total (N = 18) | |
|---|---|---|
Sex, n (%) | ||
Male | 12 (66.7) | |
Female | 6 (33.3) | |
Age (mean), years | 49.1 | |
Median (range) | 49.5 (23–65) | |
ECOG performance status, n (%) | ||
0 | 8 (44.4) | |
1 | 10 (55.6) | |
TNM stage, n (%) | ||
IIIA | 1 (6) | |
IV | 17 (94) | |
Previous regimens of systemic therapies | ||
Median (range) | 3.5 (1–9) | |
Tumor type, n (%) | ||
NSCLC | 5 (27.8) | |
Colorectal cancer | 7 (38.9) | |
Ovarian cancer | 1 (5.6) | |
Gastric cancer | 1 (5.6) | |
Thyroid cancer | 1 (5.6) | |
DLBCL | 1 (5.6) | |
Fibrosarcoma | 1 (5.6) | |
Renal cancer | 1 (5.6) | |